BIRAC

The Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8 Public Sector Enterprise established in 2012 by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. BIRAC serves as the primary interface agency between the government and the biotech entrepreneurship ecosystem, providing financial, infrastructural, institutional, and mentoring support to emerging biotech ventures. It is headquartered in New Delhi and works through a network of partner institutions across India.

BIRAC has enabled over ₹4,200 crore in funding support and has touched thousands of startups, innovators, and companies through its diverse portfolio of schemes and programs.

Role in the Startup Ecosystem

BIRAC is the single most important institutional enabler for biotech startups in India. It bridges the gap between academic research and commercial product development by providing non-dilutive grants, equity funding, and access to bio-incubation infrastructure. For biotech ventures, which typically face long development cycles and high capital requirements, BIRAC's patient capital and structured support programs are often the difference between a research idea staying in a lab and becoming a viable product.

Programs and Initiatives

BIRAC's flagship scheme is the Biotechnology Ignition Grant (BIG), the largest early-stage biotech funding program in India, providing up to ₹50 lakh for proof-of-concept work over 18 months. The BIG scheme operates through 8 partner institutions nationwide. Other programs include the Small Business Innovation Research Initiative (SBIRI) for late-stage product development, the Biotechnology Industry Partnership Programme (BIPP) for industry-led research, the SEED Fund for equity investment in startups, BioNEST for bio-incubator infrastructure, and E-YUVA for student entrepreneurship in biotechnology. BIRAC also runs the RDI Fund and joint calls with DBT for emerging areas like Bio-AI.

Notable Alumni

BIRAC-supported startups include Niramai Health Analytix (AI-based breast cancer screening), Bugworks Research (antimicrobial resistance therapeutics backed by the Gates Foundation), and Pandorum Technologies (3D bioprinting and regenerative medicine). Over 118 products from BIRAC-supported startups have been commercialized.

Who Benefits

Biotech researchers, scientists-turned-entrepreneurs, and startups working in healthcare, agriculture, industrial biotech, and environmental biotech. The BIG scheme is particularly suited for academic researchers taking their first steps toward commercialization, while SBIRI and BIPP serve more mature ventures.

Strategic Impact

BIRAC has built the institutional plumbing for India's biotech startup sector. By providing non-dilutive funding at the riskiest stages of biotech development, it has de-risked the sector for private investors and helped India grow its biotech economy. Its network of bio-incubators through BioNEST has created physical infrastructure for biotech ventures in cities beyond the metros.